Have a feature idea you'd love to see implemented?
Let us know!
AURA Aura Biosciences Inc
Price (delayed)
$9.03
Market cap
$451.06M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.73
Enterprise value
$444.74M
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet
Highlights
Aura Biosciences's EPS has increased by 11% YoY and by 3.4% QoQ
AURA's debt is down by 5% YoY
AURA's equity is up by 15% year-on-year but it is down by 9% since the previous quarter
AURA's quick ratio is down by 33% from the previous quarter and by 13% YoY
The company's net income fell by 17% YoY and by 3.1% QoQ
Key stats
What are the main financial stats of AURA
Market
Valuations
Earnings
Shares outstanding
49.95M
Market cap
$451.06M
Enterprise value
$444.74M
Price to earnings (P/E)
N/A
Price to book (P/B)
2.56
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$82.99M
EBITDA
-$79.91M
Free cash flow
-$74.51M
Per share
Balance sheet
Liquidity
EPS
-$1.73
Free cash flow per share
-$1.5
Book value per share
$3.52
Revenue per share
$0
TBVPS
$4.13
Total assets
$205.34M
Total liabilities
$30.67M
Debt
$19.08M
Equity
$174.67M
Working capital
$168.77M
Debt to equity
0.11
Current ratio
12.47
Quick ratio
11.85
Net debt/EBITDA
0.08
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-36.4%
Return on equity
-41.6%
Return on invested capital
-40.5%
Return on capital employed
-43.5%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
AURA stock price
How has the Aura Biosciences stock price performed over time
Intraday
3.2%
1 week
-9.43%
1 month
-22.49%
1 year
13.02%
YTD
1.92%
QTD
1.35%
Financial performance
How have Aura Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$93.09M
Net income
-$83.22M
Gross margin
N/A
Net margin
N/A
AURA's operating income is down by 20% year-on-year and by 3% since the previous quarter
The company's net income fell by 17% YoY and by 3.1% QoQ
Growth
What is Aura Biosciences's growth rate over time
Valuation
What is Aura Biosciences stock price valuation
P/E
N/A
P/B
2.56
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Aura Biosciences's EPS has increased by 11% YoY and by 3.4% QoQ
AURA's price to book (P/B) is 28% more than its last 4 quarters average of 2.0
AURA's equity is up by 15% year-on-year but it is down by 9% since the previous quarter
Efficiency
How efficient is Aura Biosciences business performance
AURA's return on invested capital is up by 17% year-on-year and by 3.1% since the previous quarter
The return on assets has declined by 3.1% year-on-year
Dividends
What is AURA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for AURA.
Financial health
How did Aura Biosciences financials performed over time
AURA's quick ratio is down by 33% from the previous quarter and by 13% YoY
AURA's current ratio is down by 33% since the previous quarter and by 12% year-on-year
AURA's debt is 89% less than its equity
The debt to equity has declined by 15% year-on-year but it is up by 10% since the previous quarter
AURA's equity is up by 15% year-on-year but it is down by 9% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.